Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Cymer (CYMI) -- Ignore unavailable to you. Want to Upgrade?

To: Steven Angelil who wrote (14815)	2/18/1998 7:48:00 PM
From: sepku	Read Replies (1) \| Respond to of 25960

Excellent and relevent article. Too bad it seems to indicate that the poison pill had little or nothing to do with any takeover talks -- just insurance. Style Pts.

To: Steven Angelil who wrote (14815)	2/18/1998 8:05:00 PM
From: TideGlider	Respond to of 25960

Very interesting Steven...thanks.. TG

To: Steven Angelil who wrote (14815)	2/18/1998 10:38:00 PM
From: Czechsinthemail	Respond to of 25960

Steven, This was my favorite part of the ABC article on poison-pills: Shareholder-rights plans often don't prevent takeovers, but they do achieve higher bids by encouraging negotiation and buying time for targets to seek a white knight. ÿÿÿÿ Research by Georgeson & Co., a New York investor relations firm, found that companies with poison pills sold for 8 percent higher than target companies without the plans. ÿÿÿÿ Economist Robert Comment of Washington's Analysis Group reports that poison pills actually increase the chances of a takeover because they empower a company's management to negotiate with potential purchasers. I think this explains the rationale for CYMI to adopt it. Baird